Formoterol 24 [mu]g is not associated with an increase in serious asthma exacerbations in patients with persistent asthma

Formoterol 24 [mu]g is not associated with an increase in serious asthma exacerbations in patients with persistent asthma

The primary variable was percentage of patients reporting serious (e.g. requiring hospitalization) asthma-related adverse events (AEs).

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2005-02, Vol.115 (2), p.S150
Hauptverfasser: Wolfe, J, LaForce, C, Ostrom, NK, Korenblat, P, Orevillo, C, Ziehmer, B, Till, D, Stenglein, S
Format: Artikel
Sprache:eng
Schlagworte:
Drug therapy
Medical research
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The primary variable was percentage of patients reporting serious (e.g. requiring hospitalization) asthma-related adverse events (AEs).
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2004.12.611